Premium
Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite
Author(s) -
SCADDING GLENIS K.,
BROSTOFF J.
Publication year - 1986
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.1986.tb01983.x
Subject(s) - house dust mite , medicine , dust mites , morning , desensitization (medicine) , provocation test , placebo , mite , anesthesia , allergy , dermatology , allergen , immunology , botany , receptor , alternative medicine , pathology , biology
Summary In a double‐blind placebo‐controlled cross‐over trial, low dose sublingual therapy with house dust mite was effective in relieving symptoms in 72% of the group of patients with perennial rhinitis due to house dust mite ( P < 0·03). Following active treatment, there was a significant increase in morning peak nasal inspiratory flow rate ( P < 0·01) in those who improved (thirteen out of eighteen) and resistance to nasal provocation with house dust mite also increased, in some cases up to 1000‐fold ( P < 0·05). Oral therapy is safe and avoids the side effects of desensitizing injections which can be serious. The potential for oral desensitization is great and further studies on this form of treatment are needed.